IL150259A0 - Alkylnyl-substituted propionic acid derivatives and their use against diabetes and obesity - Google Patents
Alkylnyl-substituted propionic acid derivatives and their use against diabetes and obesityInfo
- Publication number
- IL150259A0 IL150259A0 IL15025901A IL15025901A IL150259A0 IL 150259 A0 IL150259 A0 IL 150259A0 IL 15025901 A IL15025901 A IL 15025901A IL 15025901 A IL15025901 A IL 15025901A IL 150259 A0 IL150259 A0 IL 150259A0
- Authority
- IL
- Israel
- Prior art keywords
- alkylnyl
- obesity
- propionic acid
- acid derivatives
- use against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200000137 | 2000-01-28 | ||
| DKPA200001065 | 2000-07-07 | ||
| DKPA200001593 | 2000-10-25 | ||
| PCT/DK2001/000057 WO2001055086A1 (en) | 2000-01-28 | 2001-01-26 | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150259A0 true IL150259A0 (en) | 2002-12-01 |
Family
ID=27222337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15025901A IL150259A0 (en) | 2000-01-28 | 2001-01-26 | Alkylnyl-substituted propionic acid derivatives and their use against diabetes and obesity |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1254102A1 (en) |
| JP (1) | JP2003520839A (en) |
| KR (1) | KR20020090211A (en) |
| CN (1) | CN1396904A (en) |
| AU (1) | AU2831801A (en) |
| BR (1) | BR0107902A (en) |
| CA (1) | CA2396372A1 (en) |
| HU (1) | HUP0204247A3 (en) |
| IL (1) | IL150259A0 (en) |
| MX (1) | MXPA02007295A (en) |
| NO (1) | NO20023567L (en) |
| PL (1) | PL357017A1 (en) |
| WO (1) | WO2001055086A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI311133B (en) * | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| JPWO2003016265A1 (en) | 2001-08-17 | 2004-12-02 | エーザイ株式会社 | Cyclic compounds and PPAR agonists |
| RU2004114875A (en) * | 2001-10-17 | 2005-09-10 | Ново Нордиск А/С (DK) | DICARBOXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND THERAPEUTIC USE |
| US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
| ITRM20020014A1 (en) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | DERIVATIVES OF A-PHENYLTHIOCARBOXYL AND A-PHYLYOXYCARBOXYL ACIDS USEFUL FOR THE TREATMENT OF DISEASES THAT RESPOND TO THE ACTIVATION OF |
| BR0314335A (en) * | 2002-09-05 | 2005-07-26 | Novo Nordisk As | Compound, use thereof, pharmaceutical composition, and methods for treating and / or preventing nuclear receptor-mediated conditions, and of type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance, or obesity. |
| WO2005105736A1 (en) | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
| WO2006000567A2 (en) * | 2004-06-28 | 2006-01-05 | Novo Nordisk A/S | Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function |
| EP2386540A1 (en) | 2005-12-22 | 2011-11-16 | High Point Pharmaceuticals, LLC | Novel compounds, their preparation and use |
| US10307480B2 (en) | 2014-11-06 | 2019-06-04 | Scholar Rock, Inc. | Anti-pro/latent-myostatin antibodies and uses thereof |
| CN113896789A (en) | 2015-09-15 | 2022-01-07 | 供石公司 | Anti-pro/latent myostatin antibodies and uses thereof |
| HUE061656T2 (en) * | 2017-01-06 | 2023-07-28 | Scholar Rock Inc | Treating metabolic diseases by inhibiting myostatin activation |
| US11267795B2 (en) | 2020-07-22 | 2022-03-08 | Reneo Pharmaceuticals, Inc. | Crystalline PPAR-delta agonist |
| WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU678974B2 (en) * | 1992-07-03 | 1997-06-19 | Smithkline Beecham Plc | Heterocyclic compounds as pharmaceutical |
| FR2707989B1 (en) * | 1993-07-22 | 1995-10-13 | Pf Medicament | New silylated benzylamine derivatives, their salts, their manufacturing processes and the pharmaceutical compositions containing them. |
| WO1996004261A1 (en) * | 1994-07-29 | 1996-02-15 | Smithkline Beecham Plc | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
-
2001
- 2001-01-26 EP EP01946845A patent/EP1254102A1/en not_active Withdrawn
- 2001-01-26 WO PCT/DK2001/000057 patent/WO2001055086A1/en not_active Application Discontinuation
- 2001-01-26 MX MXPA02007295A patent/MXPA02007295A/en unknown
- 2001-01-26 JP JP2001555029A patent/JP2003520839A/en active Pending
- 2001-01-26 BR BR0107902-6A patent/BR0107902A/en not_active IP Right Cessation
- 2001-01-26 KR KR1020027009399A patent/KR20020090211A/en not_active Application Discontinuation
- 2001-01-26 CA CA002396372A patent/CA2396372A1/en not_active Abandoned
- 2001-01-26 IL IL15025901A patent/IL150259A0/en unknown
- 2001-01-26 AU AU28318/01A patent/AU2831801A/en not_active Abandoned
- 2001-01-26 PL PL01357017A patent/PL357017A1/en not_active Application Discontinuation
- 2001-01-26 CN CN01804239A patent/CN1396904A/en active Pending
- 2001-01-26 HU HU0204247A patent/HUP0204247A3/en unknown
-
2002
- 2002-07-26 NO NO20023567A patent/NO20023567L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2831801A (en) | 2001-08-07 |
| MXPA02007295A (en) | 2002-11-29 |
| HUP0204247A3 (en) | 2003-10-28 |
| NO20023567D0 (en) | 2002-07-26 |
| CN1396904A (en) | 2003-02-12 |
| BR0107902A (en) | 2002-11-05 |
| CA2396372A1 (en) | 2001-08-02 |
| WO2001055086A1 (en) | 2001-08-02 |
| HUP0204247A2 (en) | 2003-04-28 |
| JP2003520839A (en) | 2003-07-08 |
| NO20023567L (en) | 2002-09-25 |
| KR20020090211A (en) | 2002-11-30 |
| PL357017A1 (en) | 2004-07-12 |
| EP1254102A1 (en) | 2002-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL150260A0 (en) | Propionic acid derivatives and their use in the treatment of diabetes and obesity | |
| AU2002225356A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
| MXPA03005923A (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines. | |
| EP1367060A4 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
| EP1364957A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
| IL149374A0 (en) | New use and novel n-azabicyclo-amide derivatives | |
| ZA200410054B (en) | Propionic acid derivatives and their use as hPPARsactivators. | |
| AU2001256757A1 (en) | Agents for preventing or ameliorating insulin resistance and/or obesity | |
| HUP0204247A3 (en) | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity | |
| AU2001281850A1 (en) | Use of inulin and inulin derivatives | |
| IL155125A0 (en) | Propionic acid derivatives with ppar-alpha activating properties | |
| HUP0201486A2 (en) | Arylmalonic acid dinitrile derivatives, preparation and use thereof | |
| AU2003255463A1 (en) | Substituted isoxazole derivatives and their use in pharmaceutics | |
| GB0023323D0 (en) | Arylhydantoin derivatives and uses thereof | |
| AU2001235437A1 (en) | Isothiazolecarboxylic acid derivatives and their use as microbicides | |
| AU2001261750A1 (en) | Laminate and its use | |
| ZA200204800B (en) | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity. | |
| AU2002212176A1 (en) | Substituted phenylcyclohexane carboxylic acid amides and the use thereof | |
| ZA200204799B (en) | Propionic acid derivatives and their use in the treatment of diabetes and obesity. | |
| AU5974100A (en) | 6-carboxyphenyldihydropyridazinone derivatives and use thereof | |
| AU2002352281A1 (en) | Device for delivering liquids for human consumption and other uses | |
| AU6150400A (en) | Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof | |
| AU2001282268A1 (en) | Phenantridine derivatives and their use as anti-telomerase agent | |
| AU2001248199A1 (en) | Crystal structure for rmlc and uses thereof | |
| AU2001263934A1 (en) | Inlet device and its use |